title: [Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy].
abstract: We report the case of a 48-year-old woman who present a tricuspid, mitral and aortic regurgitation after long term ingestion of ergot alkaloids. Tricuspid and mitral fibrosis associated with retraction of the aortic leaflets are the causes of heart failure. Replacement of the three valves will be necessary. This is one, not the least complication of long-term ergotamine therapy.
authors.affiliation: Service de Cardiologie, Centre Hospitalier Régional Hutois.
authors.forename: J
authors.initials: J
authors.lastname: Goujon-Dubois
authors.forename: D
authors.initials: D
authors.lastname: el Allaf
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000009:adverse effects*; D001021:Aortic Valve / Q000601:surgery; D004878:Ergotamine / Q000009:adverse effects*; D005260:Female; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000601:surgery; D006350:Heart Valve Prosthesis; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy; D008943:Mitral Valve / Q000601:surgery; D014261:Tricuspid Valve / Q000601:surgery
chemical_list: D000316:Adrenergic alpha-Agonists; D004878:Ergotamine
vernacular_title: Le cas clinique du mois. Insuffisance trivalvulaire associée à l'utilisation chronique d'ergotamine.